Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

Improving stroke prevention in patients with atrial fibrillation.

Arts DL, Abu-Hanna A, Büller HR, Peters RJ, Eslami S, van Weert HC.

Trials. 2013 Jul 2;14:193. doi: 10.1186/1745-6215-14-193.

2.

Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey.

Brandes A, Overgaard M, Plauborg L, Dehlendorff C, Lyck F, Peulicke J, Poulsen SV, Husted S.

Clin Cardiol. 2013 Jul;36(7):427-32. doi: 10.1002/clc.22133. Epub 2013 May 13.

3.

From assessment to improvement of elderly care in general practice using decision support to increase adherence to ACOVE quality indicators: study protocol for randomized control trial.

Eslami S, Askari M, Medlock S, Arts DL, Wyatt JC, van Weert HC, de Rooij SE, Abu-Hanna A.

Trials. 2014 Mar 19;15:81. doi: 10.1186/1745-6215-15-81.

4.

An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.

Apenteng PN, Murray ET, Holder R, Hobbs FD, Fitzmaurice DA; UK GARFIELD Investigators and GARFIELD Steering Committee.

BMC Cardiovasc Disord. 2013 Apr 23;13:31. doi: 10.1186/1471-2261-13-31.

5.

Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.

Anderson DR, Gardner MJ, Putnam W, Jassal D, Brownell B, Flowerdew G, Nagpal S, Thompson K, Cox JL.

Can J Cardiol. 2005 Mar;21(3):257-66.

PMID:
15776115
6.
7.

Cluster randomized trial in the general practice research database: 2. Secondary prevention after first stroke (eCRT study): study protocol for a randomized controlled trial.

Dregan A, van Staa T, McDermott L, McCann G, Ashworth M, Charlton J, Wolfe C, Rudd A, Yardley L, Gulliford M; eCRT Research Team.

Trials. 2012 Oct 3;13:181. doi: 10.1186/1745-6215-13-181.

8.

Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.

Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Kao Yang YH.

Clin Ther. 2008 Sep;30(9):1726-36. doi: 10.1016/j.clinthera.2008.09.010.

PMID:
18840379
9.

Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey.

Sabouret P, Bricard M, Hermann MA, Cotté FE, Deret-Bixio L, Rushton-Smith S.

Arch Cardiovasc Dis. 2015 Nov;108(11):544-53. doi: 10.1016/j.acvd.2015.05.005. Epub 2015 Jun 22.

PMID:
26113478
10.

A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643].

McAlister FA, Man-Son-Hing M, Straus SE, Ghali WA, Gibson P, Anderson D, Cox J, Fradette M; Decision Aids in Atrial Fibrillation (DAAFI) Investigators.

BMC Cardiovasc Disord. 2004 May 5;4:5.

12.
13.

Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.

Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.

J Cardiovasc Electrophysiol. 2012 Jul;23(7):708-13. doi: 10.1111/j.1540-8167.2011.02257.x. Epub 2012 Jan 23.

PMID:
22268375
14.

Guideline adherence in antithrombotic treatment after concomitant ablation surgery in atrial fibrillation patients.

van Breugel HN, Gelsomino S, Lozekoot PW, Accord RE, Lucà F, Parise O, Crijns HJ, Maessen JG.

Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):313-20. doi: 10.1093/icvts/ivt522. Epub 2013 Dec 13.

15.

Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.

Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, Meeder JG, Prins MH, Lévy S, Crijns HJ; Euro Heart Survey Investigators.

Am Heart J. 2007 Jun;153(6):1006-12.

PMID:
17540203
16.

Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study.

Tulner LR, Van Campen JP, Kuper IM, Gijsen GJ, Koks CH, Mac Gillavry MR, van Tinteren H, Beijnen JH, Brandjes DP.

Drugs Aging. 2010 Jan 1;27(1):39-50. doi: 10.2165/11319540-000000000-00000. Review.

PMID:
20030431
17.

Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997. From scientific evidence to practice.

Osseby GV, Benatru I, Sochurkova D, Urbinelli R, Megherbi SE, Couvreur G, Moreau T, Wolf J, Giroud M.

Prev Med. 2004 Feb;38(2):121-8.

PMID:
14715203
18.

Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial.

Holt TA, Fitzmaurice DA, Marshall T, Fay M, Qureshi N, Dalton AR, Hobbs FD, Lasserson DS, Kearley K, Hislop J, Jin J.

Trials. 2013 Nov 13;14:385. doi: 10.1186/1745-6215-14-385.

19.

Can we predict stroke in atrial fibrillation?

Lip GY.

Clin Cardiol. 2012 Jan;35 Suppl 1:21-7. doi: 10.1002/clc.20969. Review.

20.

Cluster randomised trial in the General Practice Research Database: 1. Electronic decision support to reduce antibiotic prescribing in primary care (eCRT study).

Gulliford MC, van Staa T, McDermott L, Dregan A, McCann G, Ashworth M, Charlton J, Grieve AP, Little P, Moore MV, Yardley L; electronic Cluster Randomised Trial Research Team eCRT Research Team.

Trials. 2011 May 10;12:115. doi: 10.1186/1745-6215-12-115.

Items per page

Supplemental Content

Write to the Help Desk